Kaitlyn Dykes

12PUBLICATIONS
48CO-AUTHORS
PhysiotherapyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Epidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 25, 2026
Improved Outcomes with TKI Maintenance Following Brexucabtagene Autoleucel in Philadelphia-chromosome ALL.

|May 19, 2026
Consensus recommendations for CAR T-cell administration in adult acute lymphoblastic leukemia: a modified Delphi study.

|Feb 05, 2026
Blinatumomab nonresponse correlates with poor survival after brexucabtagene autoleucel in B-cell ALL.

Hrishikesh Krishna Srinagesh, Vishal K Gupta, Amy Zhang

|Oct 06, 2025
CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia.

Yannis K Valtis, Chenyu Lin, David Nemirovsky

|Jun 24, 2025
A prospective clinical trial of GVHD prophylaxis with posttransplant cyclophosphamide and abatacept.

Divya Koura, Kaitlyn Dykes, Aaron Goodman

|May 07, 2025
Outcomes of brexucabtagene autoleucel in patients with relapsed/refractory acute lymphoblastic leukemia with CNS involvement.

Ibrahim N Muhsen, Gregory W Roloff, Rawan Faramand

Pageof 2

Frequent Collaborators

6 joint publications

Gregory W Roloff

6 joint publications

Lori S Muffly

6 joint publications

Joshua Sasine

6 joint publications

Noelle V Frey